Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial
Jianhui Ma
◽
Yan Song
◽
Jianzhong Shou
◽
Yuxian Bai
◽
Hanzhong Li
◽
...
2014 ◽
Vol 21
(7)
◽
pp. 741-741
2014 ◽
Vol 21
(7)
◽
pp. 740-740
◽
Ryuichi Mizuno
◽
Akira Miyajima
◽
Mototsugu Oya
2012 ◽
Vol 23
◽
pp. ix271-ix272
2012 ◽
Vol 48
(3)
◽
pp. 333-339
◽
E. Calvo
◽
B. Escudier
◽
R.J. Motzer
◽
S. Oudard
◽
T.E. Hutson
◽
...
2015 ◽
Vol 75
(5)
◽
pp. 1025-1035
◽
Inkeun Park
◽
Jae-Lyun Lee
◽
Jin-Hee Ahn
◽
Dae-Ho Lee
◽
Kyoo-Hyung Lee
◽
...
2020 ◽
Vol 40
(12)
◽
pp. 7037-7043
VITTORIO GEBBIA
◽
ANDREA GIRLANDO
◽
ALFIO DI GRAZIA
◽
IVAN FAZIO
◽
NICOLÒ BORSELLINO
◽
...
2012 ◽
Vol 11
(1)
◽
pp. e83-e83a
S. Bracarda
◽
S. Rottey
◽
A. Bahl
◽
C. Eichelberg
◽
B. Mellado
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4601-4601
V. Grünwald
◽
P. I. Karakiewicz
◽
S. E. Bavbek
◽
K. Miller
◽
J. H. Machiels
◽
...
2013 ◽
Vol 36
(3)
◽
pp. 95-100
◽
Lothar Bergmann
◽
Peter J. Goebell
◽
Ulrich Kube
◽
Manfred Kindler
◽
Edwin Herrmann
◽
...
2014 ◽
Vol 46
(4)
◽
pp. 339-347
◽
Kwonoh Park
◽
Jae-Lyun Lee
◽
Jin-Hee Ahn
◽
Kyoo Hyung Lee
◽
In-Gab Jeong
◽
...
Close
Export Citation Format
Close
Share Document
Close